$SGRY
Surgery Partners, Inc. Stock $sgry

$sgry Overview Financials Valuation SEC Filings Company Website

2016 Q4 Form 10-Q Financial Statement

#000163883316000055 Filed on November 10, 2016

Income Statement

Concept	2016 Q4	2016 Q3	2015 Q3
Revenue	$306.0M	$282.7M	$239.6M
YoY Change	16.21%	17.98%	214.01%
Cost Of Revenue	$214.2M	$201.4M	$168.8M
YoY Change	16.96%	19.29%	272.04%
Gross Profit	$91.75M	$81.29M	$70.78M
YoY Change	14.48%	14.85%	128.86%
Gross Profit Margin	29.98%	28.76%	29.54%
Selling, General & Admin	$39.80M	$36.70M	$28.30M
YoY Change	-1.0%	29.68%	139.83%
% of Gross Profit	43.38%	45.15%	39.98%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$10.60M	$9.713M	$8.611M
YoY Change	17.78%	12.8%	203.85%
% of Gross Profit	11.55%	11.95%	12.17%
Operating Expenses	$50.40M	$239.8M	$195.3M
YoY Change	2.65%	22.79%	244.8%
Operating Profit	$41.35M	$42.85M	$44.27M
YoY Change	33.19%	-3.22%	125.27%
Interest Expense	-$23.90M	-$26.48M	-$26.57M
YoY Change	10.65%	-0.37%	135.93%
% of Operating Profit	-57.79%	-61.79%	-60.02%
Other Income/Expense, Net	$700.0K	-$4.100M	$300.0K
YoY Change	-100.59%	-1466.67%
Pretax Income	$42.70M	$12.64M	$17.70M
YoY Change	-135.2%	-28.59%	110.95%
Income Tax	$4.600M	-$1.694M	$3.917M
% Of Pretax Income	10.77%	-13.4%	22.13%
Net Earnings	$16.86M	-$2.338M	-$3.122M
YoY Change	0.73%	-25.11%	-54.81%
Net Earnings / Revenue	5.51%	-0.83%	-1.3%
Basic Earnings Per Share	$0.35	-$0.05	-$0.10
Diluted Earnings Per Share	$0.35	-$0.05	-$0.10
COMMON SHARES
Basic Shares Outstanding	48.49M shares	48.02M shares	32.05M shares
Diluted Shares Outstanding		48.02M shares	32.05M shares

Balance Sheet

Concept	2016 Q4	2016 Q3	2015 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$69.70M	$55.20M	$56.80M
YoY Change	20.38%	-2.82%
Cash & Equivalents	$69.70M	$55.21M	$56.85M
Short-Term Investments
Other Short-Term Assets	$11.34M	$10.39M	$9.662M
YoY Change	34.75%	7.51%
Inventory	$28.78M	$26.87M	$24.75M
Prepaid Expenses	$11.16M	$11.52M	$8.122M
Receivables	$220.6M	$206.0M	$164.6M
Other Receivables	$9.500M	$9.500M	$10.00M
Total Short-Term Assets	$362.0M	$328.7M	$288.0M
YoY Change	16.4%	14.14%
LONG-TERM ASSETS
Property, Plant & Equipment	$204.3M	$199.6M	$173.8M
YoY Change	10.67%	14.84%
Goodwill	$1.555B	$1.531B	$1.330B
YoY Change	10.46%	15.14%
Intangibles	$48.02M	$48.67M	$53.14M
YoY Change	-10.35%	-8.4%
Long-Term Investments	$39.50M	$39.40M	$36.60M
YoY Change	7.05%	7.65%
Other Assets	$16.44M	$13.83M	$7.510M
YoY Change	56.39%	84.15%
Total Long-Term Assets	$1.943B	$1.920B	$1.604B
YoY Change	8.34%	19.74%
TOTAL ASSETS
Total Short-Term Assets	$362.0M	$328.7M	$288.0M
Total Long-Term Assets	$1.943B	$1.920B	$1.604B
Total Assets	$2.305B	$2.249B	$1.892B
YoY Change	9.53%	18.88%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$49.77M	$44.45M	$40.81M
YoY Change	9.76%	8.93%
Accrued Expenses	$71.00M	$69.80M	$51.10M
YoY Change	31.73%	36.59%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$27.80M	$29.10M	$27.70M
YoY Change	2.21%	5.05%
Total Short-Term Liabilities	$186.7M	$178.7M	$176.2M
YoY Change	3.0%	1.41%
LONG-TERM LIABILITIES
Long-Term Debt	$1.467B	$1.411B	$1.425B
YoY Change	14.44%	-1.01%
Other Long-Term Liabilities	$76.27M	$87.43M	$83.78M
YoY Change	-10.92%	4.36%
Total Long-Term Liabilities	$76.27M	$87.43M	$83.78M
YoY Change	-10.92%	4.36%
TOTAL LIABILITIES
Total Short-Term Liabilities	$186.7M	$178.7M	$176.2M
Total Long-Term Liabilities	$76.27M	$87.43M	$83.78M
Total Liabilities	$263.0M	$266.1M	$260.0M
YoY Change	-1.47%	2.36%
SHAREHOLDERS EQUITY
Retained Earnings	-$311.4M	-$328.2M	-$337.5M
YoY Change	-2.95%	-2.76%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$9.677M	-$8.331M	-$277.4M
YoY Change
Total Liabilities & Shareholders Equity	$2.305B	$2.249B	$1.892B
YoY Change	9.53%	18.88%

Cashflow Statement

Concept	2016 Q4	2016 Q3	2015 Q3
OPERATING ACTIVITIES
Net Income	$16.86M	-$2.338M	-$3.122M
YoY Change	0.73%	-25.11%	-54.81%
Depreciation, Depletion And Amortization	$10.60M	$9.713M	$8.611M
YoY Change	17.78%	12.8%	203.85%
Cash From Operating Activities	$32.30M	$18.90M	$29.30M
YoY Change	33.47%	-35.49%	104.9%
INVESTING ACTIVITIES
Capital Expenditures	-$10.70M	-$8.000M	-$6.600M
YoY Change	-30.07%	21.21%	450.0%
Acquisitions
YoY Change
Other Investing Activities	-$19.60M	-$13.00M	-$20.20M
YoY Change	-75.5%	-35.64%	3266.67%
Cash From Investing Activities	-$30.30M	-$21.00M	-$26.80M
YoY Change	-68.21%	-21.64%	1388.89%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	12.50M	5.800M	6.400M
YoY Change	-82.71%	-9.38%	-145.39%
NET CHANGE
Cash From Operating Activities	32.30M	18.90M	29.30M
Cash From Investing Activities	-30.30M	-21.00M	-26.80M
Cash From Financing Activities	12.50M	5.800M	6.400M
Net Change In Cash	14.50M	3.700M	8.900M
YoY Change	1108.33%	-58.43%	-656.25%
FREE CASH FLOW
Cash From Operating Activities	$32.30M	$18.90M	$29.30M
Capital Expenditures	-$10.70M	-$8.000M	-$6.600M
Free Cash Flow	$43.00M	$26.90M	$35.90M
YoY Change	8.86%	-25.07%	131.61%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2016
	dei	Document Period End Date DocumentPeriodEndDate	2016-09-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001638833
	sgry	Incentive Payments Recognizedfor Certain Hospitalsand Physician Practices That Demonstrate Meaningful Useof Certified Electronic Health Record Technology IncentivePaymentsRecognizedforCertainHospitalsandPhysicianPracticesThatDemonstrateMeaningfulUseofCertifiedElectronicHealthRecordTechnology	-107000	USD
CY2016Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	48493738	shares
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	Surgery Partners, Inc.
CY2016Q3	sgry	Acquisitionescrowreceivablecurrent Acquisitionescrowreceivablecurrent	0	USD
	sgry	Amortizationof Unfavorable Lease Liability AmortizationofUnfavorableLeaseLiability	323000	USD
	sgry	Amortizationof Unfavorable Lease Liability AmortizationofUnfavorableLeaseLiability	323000	USD
CY2015Q4	sgry	Business Combination Consideration Transferred Payable Current BusinessCombinationConsiderationTransferredPayableCurrent	16768000	USD
CY2016Q3	sgry	Business Combination Consideration Transferred Payable Current BusinessCombinationConsiderationTransferredPayableCurrent	0	USD
CY2015Q3	sgry	Business Combination Contingent Compensation Expense BusinessCombinationContingentCompensationExpense	0	USD
	sgry	Business Combination Contingent Compensation Expense BusinessCombinationContingentCompensationExpense	0	USD
CY2016Q3	sgry	Business Combination Contingent Compensation Expense BusinessCombinationContingentCompensationExpense	1530000	USD
	sgry	Business Combination Contingent Compensation Expense BusinessCombinationContingentCompensationExpense	3060000	USD
CY2015Q4	sgry	Business Combination Indemnification Assets Receivable BusinessCombinationIndemnificationAssetsReceivable	1072000	USD
CY2016Q3	sgry	Business Combination Indemnification Assets Receivable BusinessCombinationIndemnificationAssetsReceivable	1072000	USD
CY2015Q3	sgry	Business Combination Integration Related Costs And Merger Costs BusinessCombinationIntegrationRelatedCostsAndMergerCosts	1541000	USD
	sgry	Business Combination Integration Related Costs And Merger Costs BusinessCombinationIntegrationRelatedCostsAndMergerCosts	15189000	USD
CY2016Q3	sgry	Business Combination Integration Related Costs And Merger Costs BusinessCombinationIntegrationRelatedCostsAndMergerCosts	2471000	USD
	sgry	Business Combination Integration Related Costs And Merger Costs BusinessCombinationIntegrationRelatedCostsAndMergerCosts	8579000	USD
CY2015Q3	sgry	Business Combination Practice Acquisition Costs BusinessCombinationPracticeAcquisitionCosts	292000	USD
	sgry	Business Combination Practice Acquisition Costs BusinessCombinationPracticeAcquisitionCosts	292000	USD
CY2016Q3	sgry	Business Combination Practice Acquisition Costs BusinessCombinationPracticeAcquisitionCosts	607000	USD
	sgry	Business Combination Practice Acquisition Costs BusinessCombinationPracticeAcquisitionCosts	2200000	USD
CY2015Q3	sgry	Collaborative Tax Agreement Percentageof Cash Savings Requiredto Pay CollaborativeTaxAgreementPercentageofCashSavingsRequiredtoPay	0.85
	sgry	Debt Instrument Prepayment Penalty Amount DebtInstrumentPrepaymentPenaltyAmount	0	USD
	sgry	Debt Instrument Prepayment Penalty Amount DebtInstrumentPrepaymentPenaltyAmount	4900000	USD
CY2015Q4	sgry	Debt Instrument Unamortized Discount Premiumand Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumandDebtIssuanceCostsNet	30622000	USD
CY2016Q3	sgry	Debt Instrument Unamortized Discount Premiumand Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumandDebtIssuanceCostsNet	34037000	USD
CY2015Q3	sgry	Earnings Before Interest Taxes Depreciationand Amortization EarningsBeforeInterestTaxesDepreciationandAmortization	39857000	USD
	sgry	Earnings Before Interest Taxes Depreciationand Amortization EarningsBeforeInterestTaxesDepreciationandAmortization	114299000	USD
CY2016Q3	sgry	Earnings Before Interest Taxes Depreciationand Amortization EarningsBeforeInterestTaxesDepreciationandAmortization	44748000	USD
	sgry	Earnings Before Interest Taxes Depreciationand Amortization EarningsBeforeInterestTaxesDepreciationandAmortization	129205000	USD
CY2015Q4	sgry	Escrow Deposit Current EscrowDepositCurrent	13984000	USD
CY2016Q3	sgry	Escrow Deposit Current EscrowDepositCurrent	9288000	USD
CY2015Q4	sgry	Escrow Deposit Noncurrent EscrowDepositNoncurrent	8408000	USD
CY2016Q3	sgry	Escrow Deposit Noncurrent EscrowDepositNoncurrent	1700000	USD
CY2015Q4	sgry	Escrow Liability Current EscrowLiabilityCurrent	13984000	USD
CY2016Q3	sgry	Escrow Liability Current EscrowLiabilityCurrent	9288000	USD
CY2015Q4	sgry	Escrow Liability Noncurrent EscrowLiabilityNoncurrent	8408000	USD
CY2016Q3	sgry	Escrow Liability Noncurrent EscrowLiabilityNoncurrent	1700000	USD
	sgry	Finiteand Indefinitelived Intangible Asset Additions FiniteandIndefinitelivedIntangibleAssetAdditions	2763000	USD
	sgry	Finiteand Indefinitelived Intangible Asset Disposals FiniteandIndefinitelivedIntangibleAssetDisposals	22000	USD
CY2015Q3	sgry	Incentive Payments Recognizedfor Certain Hospitalsand Physician Practices That Demonstrate Meaningful Useof Certified Electronic Health Record Technology IncentivePaymentsRecognizedforCertainHospitalsandPhysicianPracticesThatDemonstrateMeaningfulUseofCertifiedElectronicHealthRecordTechnology	-57000	USD
CY2016Q3	sgry	Incentive Payments Recognizedfor Certain Hospitalsand Physician Practices That Demonstrate Meaningful Useof Certified Electronic Health Record Technology IncentivePaymentsRecognizedforCertainHospitalsandPhysicianPracticesThatDemonstrateMeaningfulUseofCertifiedElectronicHealthRecordTechnology	-364000	USD
	sgry	Incentive Payments Recognizedfor Certain Hospitalsand Physician Practices That Demonstrate Meaningful Useof Certified Electronic Health Record Technology IncentivePaymentsRecognizedforCertainHospitalsandPhysicianPracticesThatDemonstrateMeaningfulUseofCertifiedElectronicHealthRecordTechnology	-269000	USD
CY2016Q3	sgry	Increaseof Revenueas Resultof Changesin Estimatesto Thirdparty Settlements Relatedto Prior Years IncreaseofRevenueasResultofChangesinEstimatestoThirdpartySettlementsRelatedtoPriorYears	4700000	USD
	sgry	Increaseof Revenueas Resultof Changesin Estimatesto Thirdparty Settlements Relatedto Prior Years IncreaseofRevenueasResultofChangesinEstimatestoThirdpartySettlementsRelatedtoPriorYears	6700000	USD
	sgry	Intangible Assets Professional Recruitment Expense IntangibleAssetsProfessionalRecruitmentExpense	482000	USD
CY2015Q4	sgry	Lease Obligation Noncurrent LeaseObligationNoncurrent	53927000	USD
CY2016Q3	sgry	Lease Obligation Noncurrent LeaseObligationNoncurrent	53013000	USD
CY2015Q4	sgry	Medical Malpractice Liability Noncurrent MedicalMalpracticeLiabilityNoncurrent	6339000	USD
CY2016Q3	sgry	Medical Malpractice Liability Noncurrent MedicalMalpracticeLiabilityNoncurrent	6339000	USD
	sgry	Non Controlling Interest Acquisitionsand Disposalsof Interestsheldby Non Controlling Interest Holders Net NonControllingInterestAcquisitionsandDisposalsofInterestsheldbyNonControllingInterestHoldersNet	20700000	USD
CY2016Q3	sgry	Number Of Surgical Facilities Owned NumberOfSurgicalFacilitiesOwned	104	surgical_facility
CY2016Q3	sgry	Numberof Surgical Facilities Owned Consolidated NumberofSurgicalFacilitiesOwnedConsolidated	93	surgical_facility
CY2016Q3	sgry	Numberof Surgical Facilities Owned Majority Interest NumberofSurgicalFacilitiesOwnedMajorityInterest	73	surgical_facility
CY2015Q4	sgry	Optical Products Receivable OpticalProductsReceivable	8400000	USD
CY2016Q3	sgry	Optical Products Receivable OpticalProductsReceivable	8407000	USD
	sgry	Proceedsfrom Paymentsof Distributionsto Affiliates ProceedsfromPaymentsofDistributionstoAffiliates	-11991000	USD
	sgry	Proceedsfrom Paymentsof Distributionsto Affiliates ProceedsfromPaymentsofDistributionstoAffiliates	1105000	USD
	sgry	Redeemable Noncontrolling Interest Decrease From Distributions To Noncontrolling Interest Holders RedeemableNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	13031000	USD
	sgry	Redeemable Noncontrolling Interest Increase Decrease From Redemptions Or Purchase Of Interests RedeemableNoncontrollingInterestIncreaseDecreaseFromRedemptionsOrPurchaseOfInterests	1157000	USD
CY2015Q3	sgry	Related Party Transaction Annual Management Fee Paidper Agreement RelatedPartyTransactionAnnualManagementFeePaidperAgreement	750000	USD
	sgry	Related Party Transaction Annual Management Fee Paidper Agreement RelatedPartyTransactionAnnualManagementFeePaidperAgreement	2250000	USD
CY2016Q3	sgry	Related Party Transaction Annual Management Fee Paidper Agreement RelatedPartyTransactionAnnualManagementFeePaidperAgreement	0	USD
	sgry	Related Party Transaction Annual Management Fee Paidper Agreement RelatedPartyTransactionAnnualManagementFeePaidperAgreement	0	USD
CY2015Q3	sgry	Tax Receivable Agreement Expense TaxReceivableAgreementExpense	0	USD
	sgry	Tax Receivable Agreement Expense TaxReceivableAgreementExpense	0	USD
CY2016Q3	sgry	Tax Receivable Agreement Expense TaxReceivableAgreementExpense	3733000	USD
	sgry	Tax Receivable Agreement Expense TaxReceivableAgreementExpense	3733000	USD
CY2015Q4	sgry	Third Party Settlements Payable Current ThirdPartySettlementsPayableCurrent	5222000	USD
CY2015Q4	sgry	Third Party Settlements Payable Current ThirdPartySettlementsPayableCurrent	5200000	USD
CY2016Q3	sgry	Third Party Settlements Payable Current ThirdPartySettlementsPayableCurrent	2200000	USD
CY2016Q3	sgry	Third Party Settlements Payable Current ThirdPartySettlementsPayableCurrent	2220000	USD
CY2015	sgry	Variable Interest Entity Numberof Facilities VariableInterestEntityNumberofFacilities	4	surgical_facility
CY2015	sgry	Variable Interest Entity Numberof Facilities VariableInterestEntityNumberofFacilities	3	Anesthesia_Practice
CY2015	sgry	Variable Interest Entity Numberof Facilities VariableInterestEntityNumberofFacilities	1	Practice
	sgry	Variable Interest Entity Numberof Facilities VariableInterestEntityNumberofFacilities	4	surgical_facility
	sgry	Variable Interest Entity Numberof Facilities VariableInterestEntityNumberofFacilities	1	Practice
	sgry	Variable Interest Entity Numberof Facilities VariableInterestEntityNumberofFacilities	3	Anesthesia_Practice
CY2015Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	45341000	USD
CY2016Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	44453000	USD
CY2015Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	177757000	USD
CY2016Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	205979000	USD
CY2015Q4	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	5476000	USD
CY2016Q3	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	6097000	USD
CY2015Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment Excluding Capital Leased Assets AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentExcludingCapitalLeasedAssets	70238000	USD
CY2016Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment Excluding Capital Leased Assets AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentExcludingCapitalLeasedAssets	86737000	USD
CY2015Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	316294000	USD
CY2016Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	319397000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1326000	USD
CY2015Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	18322000	USD
CY2016Q3	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	316000	USD
CY2015Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	482000	USD
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	1561000	USD
CY2016Q3	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	485000	USD
CY2016Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	28217000	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	4966000	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	5295000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	7154000	USD
CY2015Q4	us-gaap	Assets Assets	2104443000	USD
CY2016Q3	us-gaap	Assets Assets	2248725000	USD
CY2015Q4	us-gaap	Assets Current AssetsCurrent	310957000	USD
CY2016Q3	us-gaap	Assets Current AssetsCurrent	328728000	USD
CY2015Q3	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	0	USD
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	0	USD
CY2015Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	14049000	USD
CY2016Q3	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	14892000	USD
CY2015Q3	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	1249000	USD
CY2015Q3	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	1200000	USD
	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	14897000	USD
	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	14900000	USD
CY2016Q3	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	1864000	USD
	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	6361000	USD
CY2015Q4	us-gaap	Capital Lease Obligations CapitalLeaseObligations	11316000	USD
CY2016Q3	us-gaap	Capital Lease Obligations CapitalLeaseObligations	13425000	USD
CY2015Q4	us-gaap	Capital Leases Balance Sheet Assets By Major Class Net CapitalLeasesBalanceSheetAssetsByMajorClassNet	12300000	USD
CY2016Q3	us-gaap	Capital Leases Balance Sheet Assets By Major Class Net CapitalLeasesBalanceSheetAssetsByMajorClassNet	14600000	USD
CY2015Q4	us-gaap	Capital Leases Lessee Balance Sheet Assets By Major Class Accumulated Deprecation CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation	10500000	USD
CY2016Q3	us-gaap	Capital Leases Lessee Balance Sheet Assets By Major Class Accumulated Deprecation CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation	10900000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	74920000	USD
CY2015Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	56848000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	57933000	USD
CY2016Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	55209000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-18072000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-2724000	USD
CY2015Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2016Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2015Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2016Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2015Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	48156990	shares
CY2016Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	48511563	shares
CY2015Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	48156990	shares
CY2016Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	48511563	shares
CY2015Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3122000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-15310000	USD
CY2016Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2338000	USD
CY2016Q3	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	16672000	USD
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	54392000	USD
	us-gaap	Professional Fees ProfessionalFees	60813000	USD
CY2015Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	119655000	USD
CY2016Q3	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	14334000	USD
CY2016Q3	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	123343000	USD
CY2015Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	8611000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	25538000	USD
CY2016Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	9713000	USD
CY2015Q3	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	13784000	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	36751000	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	46983000	USD
	us-gaap	Income Loss From Equity Method Investments Net Of Dividends Or Distributions IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions	316000	USD
	us-gaap	Income Loss From Equity Method Investments Net Of Dividends Or Distributions IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions	138000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-7409000	USD
CY2015Q3	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	16906000	USD
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	52061000	USD
CY2016Q3	us-gaap	Goodwill Goodwill	1531370000	USD
CY2016Q3	us-gaap	Deferred Compensation Plan Assets DeferredCompensationPlanAssets	1659000	USD
CY2016Q3	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	1593000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	7419000	USD
CY2015Q3	us-gaap	Cost Of Revenue CostOfRevenue	168821000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	486152000	USD
CY2016Q3	us-gaap	Cost Of Revenue CostOfRevenue	201394000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	1903000	USD
CY2016Q3	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	123600000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Liabilities Net Noncurrent DeferredTaxAssetsLiabilitiesNetNoncurrent	94105000	USD
CY2016Q3	us-gaap	Deferred Tax Assets Liabilities Net Noncurrent DeferredTaxAssetsLiabilitiesNetNoncurrent	90233000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	606949000	USD
CY2015Q4	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent	1608000	USD
CY2016Q3	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent	1659000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	28984000	USD
CY2015Q3	us-gaap	Dividends Sharebased Compensation Stock DividendsSharebasedCompensationStock	426000	USD
	us-gaap	Dividends Sharebased Compensation Stock DividendsSharebasedCompensationStock	1279000	USD
CY2016Q3	us-gaap	Dividends Sharebased Compensation Stock DividendsSharebasedCompensationStock	691000	USD
	us-gaap	Dividends Sharebased Compensation Stock DividendsSharebasedCompensationStock	1326000	USD
CY2015Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.10
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.48
CY2016Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.15
CY2015Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.10
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.48
CY2016Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.15
CY2015Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	26307000	USD
CY2016Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	24717000	USD
CY2015Q4	us-gaap	Estimated Insurance Recoveries EstimatedInsuranceRecoveries	6300000	USD
CY2016Q3	us-gaap	Estimated Insurance Recoveries EstimatedInsuranceRecoveries	6100000	USD
CY2015Q3	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-1161000	USD
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	1522000	USD
CY2016Q3	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-572000	USD
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-1697000	USD
CY2015Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2016Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-3595000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-11876000	USD
CY2015Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	11236000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	34944000	USD
CY2016Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	14985000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	42205000	USD
CY2016Q3	us-gaap	Liabilities Current LiabilitiesCurrent	178654000	USD
CY2016Q3	us-gaap	Minority Interest MinorityInterest	325808000	USD
	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	36412000	USD
CY2015Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3917000	USD
CY2016Q3	us-gaap	Long Term Accounts Notes And Loans Receivable Net Noncurrent LongTermAccountsNotesAndLoansReceivableNetNoncurrent	809000	USD
CY2015Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	1228112000	USD
CY2015Q4	us-gaap	Goodwill Goodwill	1407927000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	8368000	USD
CY2016Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1694000	USD
	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	123796000	USD
	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	-353000	USD
CY2015Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	17701000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	45119000	USD
CY2016Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	12640000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	49479000	USD
CY2015Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	1320000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	2866000	USD
CY2016Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	1167000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	3007000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2496000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	34538000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	38480000	USD
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-4989000	USD
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-14076000	USD
CY2015Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	53568000	USD
CY2016Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	48673000	USD
CY2015Q3	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-26573000	USD
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-78507000	USD
CY2016Q3	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-26475000	USD
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-74863000	USD
CY2015Q4	us-gaap	Interest Payable Current InterestPayableCurrent	5410000	USD
CY2016Q3	us-gaap	Interest Payable Current InterestPayableCurrent	18844000	USD
CY2015Q4	us-gaap	Inventory Net InventoryNet	25591000	USD
CY2016Q3	us-gaap	Inventory Net InventoryNet	26867000	USD
CY2015Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	34103000	USD
CY2016Q3	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	34274000	USD
CY2015Q3	us-gaap	Labor And Related Expense LaborAndRelatedExpense	66072000	USD
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	188405000	USD
CY2016Q3	us-gaap	Labor And Related Expense LaborAndRelatedExpense	85724000	USD
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	266401000	USD
CY2015Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2104443000	USD
CY2016Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2248725000	USD
CY2015Q4	us-gaap	Liabilities Current LiabilitiesCurrent	181289000	USD
CY2016Q3	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	1357824000	USD
CY2015Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	27247000	USD
CY2016Q3	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	29105000	USD
CY2015Q4	us-gaap	Long Term Debt And Capital Lease Obligations Including Current Maturities LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities	1255359000	USD
	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	39786000	USD
CY2016Q3	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	15703000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	0	USD
CY2016Q3	us-gaap	Long Term Debt And Capital Lease Obligations Including Current Maturities LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities	1386929000	USD
CY2015Q4	us-gaap	Minority Interest MinorityInterest	301955000	USD
	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	13047000	USD
	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	33936000	USD
CY2016Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	0	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	0	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-38880000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	58808000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-39484000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-154395000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	60292000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	92863000	USD
CY2015Q3	us-gaap	Net Income Loss NetIncomeLoss	-3122000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-15310000	USD
CY2016Q3	us-gaap	Net Income Loss NetIncomeLoss	-2338000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-7409000	USD
CY2015Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	16906000	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	52061000	USD
CY2016Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	16672000	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	54392000	USD
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	segment
CY2016Q3	us-gaap	Number Of States In Which Entity Operates NumberOfStatesInWhichEntityOperates	29	state
CY2015Q4	us-gaap	Off Market Lease Unfavorable OffMarketLeaseUnfavorable	1996000	USD
CY2016Q3	us-gaap	Off Market Lease Unfavorable OffMarketLeaseUnfavorable	1752000	USD
CY2015Q3	us-gaap	Operating Expenses OperatingExpenses	195325000	USD
	us-gaap	Operating Expenses OperatingExpenses	572943000	USD
CY2016Q3	us-gaap	Operating Expenses OperatingExpenses	239834000	USD
	us-gaap	Operating Expenses OperatingExpenses	711362000	USD
CY2015Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	44274000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	123626000	USD
CY2016Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	42848000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	128075000	USD
CY2015Q3	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	11211000	USD
	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	33267000	USD
CY2016Q3	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	13204000	USD
	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	38712000	USD
CY2015Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	22133000	USD
CY2016Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	26259000	USD
CY2015Q4	us-gaap	Other Assets Current OtherAssetsCurrent	10777000	USD
CY2016Q3	us-gaap	Other Assets Current OtherAssetsCurrent	10388000	USD
CY2015Q4	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	4211000	USD
CY2016Q3	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	4977000	USD
CY2015Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	10509000	USD
CY2016Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	13830000	USD
CY2015Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	0	USD
CY2015Q3	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	13928000	USD
	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	44539000	USD
CY2015Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	68410000	USD
CY2016Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	71091000	USD
CY2015Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	85613000	USD
CY2016Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	87429000	USD
CY2015Q3	us-gaap	Other Nonrecurring Income Expense OtherNonrecurringIncomeExpense	-330000	USD
	us-gaap	Other Nonrecurring Income Expense OtherNonrecurringIncomeExpense	-356000	USD
CY2016Q3	us-gaap	Other Nonrecurring Income Expense OtherNonrecurringIncomeExpense	0	USD
	us-gaap	Other Nonrecurring Income Expense OtherNonrecurringIncomeExpense	97000	USD
CY2015Q4	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	7694000	USD
CY2016Q3	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	9774000	USD
CY2015Q4	us-gaap	Payables To Customers PayablesToCustomers	11424000	USD
CY2016Q3	us-gaap	Payables To Customers PayablesToCustomers	14428000	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	14296000	USD
	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	51195000	USD
	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	49443000	USD
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	1448000	USD
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	32562000	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	126018000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	18115000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	28377000	USD
CY2015Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2016Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2015Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2016Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2015Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2016Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2015Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2016Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2015Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2016Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2015Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	34620000	USD
CY2016Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	30313000	USD
CY2016Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	11518000	USD
	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	11193000	USD
	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	0	USD
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	85432000	USD
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	580945000	USD
	us-gaap	Proceeds From Long Term Capital Lease Obligations ProceedsFromLongTermCapitalLeaseObligations	3783000	USD
	us-gaap	Proceeds From Long Term Capital Lease Obligations ProceedsFromLongTermCapitalLeaseObligations	-646000	USD
CY2015Q3	us-gaap	Professional Fees ProfessionalFees	17233000	USD
	us-gaap	Professional Fees ProfessionalFees	48144000	USD
CY2016Q3	us-gaap	Professional Fees ProfessionalFees	20856000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	453957000	USD
CY2015Q4	us-gaap	Restricted Cash And Investments Noncurrent RestrictedCashAndInvestmentsNoncurrent	316000	USD
CY2015Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2015Q3	us-gaap	Profit Loss ProfitLoss	13784000	USD
	us-gaap	Profit Loss ProfitLoss	36751000	USD
CY2016Q3	us-gaap	Profit Loss ProfitLoss	14334000	USD
	us-gaap	Profit Loss ProfitLoss	46983000	USD
CY2015Q4	us-gaap	Property Plant And Equipment Gross Excluding Capital Leased Assets PropertyPlantAndEquipmentGrossExcludingCapitalLeasedAssets	254788000	USD
CY2016Q3	us-gaap	Property Plant And Equipment Gross Excluding Capital Leased Assets PropertyPlantAndEquipmentGrossExcludingCapitalLeasedAssets	286339000	USD
CY2015Q4	us-gaap	Property Plant And Equipment Net Excluding Capital Leased Assets PropertyPlantAndEquipmentNetExcludingCapitalLeasedAssets	184550000	USD
CY2016Q3	us-gaap	Property Plant And Equipment Net Excluding Capital Leased Assets PropertyPlantAndEquipmentNetExcludingCapitalLeasedAssets	199602000	USD
CY2015Q3	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	5840000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	16049000	USD
CY2016Q3	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	8514000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	15931000	USD
CY2015Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	183439000	USD
CY2016Q3	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	182298000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	63461000	USD
CY2016Q3	us-gaap	Restricted Cash And Investments Noncurrent RestrictedCashAndInvestmentsNoncurrent	315000	USD
CY2015Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-320804000	USD
CY2016Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-328213000	USD
CY2015Q3	us-gaap	Revenues Revenues	239599000	USD
	us-gaap	Revenues Revenues	696569000	USD
CY2016Q3	us-gaap	Revenues Revenues	282682000	USD
	us-gaap	Revenues Revenues	839437000	USD
CY2016Q3	us-gaap	Security Deposit SecurityDeposit	4792000	USD
CY2015Q4	us-gaap	Self Insurance Reserve SelfInsuranceReserve	9500000	USD
CY2016Q3	us-gaap	Self Insurance Reserve SelfInsuranceReserve	9300000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	1279000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	1326000	USD
	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	USD
CY2015Q4	us-gaap	Stockholders Equity StockholdersEquity	-4028000	USD
CY2016Q3	us-gaap	Stockholders Equity StockholdersEquity	-8331000	USD
CY2015Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	297927000	USD
CY2016Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	317477000	USD
CY2015Q3	us-gaap	Supplies Expense SuppliesExpense	60377000	USD
	us-gaap	Supplies Expense SuppliesExpense	176550000	USD
CY2016Q3	us-gaap	Supplies Expense SuppliesExpense	65907000	USD
	us-gaap	Supplies Expense SuppliesExpense	196484000	USD
CY2015Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	1977000	USD
CY2016Q3	us-gaap	Taxes Payable Current TaxesPayableCurrent	3243000	USD
CY2016Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2015Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	32054089	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	32054089	shares
CY2016Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	48019652	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	48018706	shares
CY2015Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	32054089	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	32054089	shares
CY2016Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	48019652	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	48018706	shares
	us-gaap	Nature Of Operations NatureOfOperations	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;text-align:left;padding-left:24px;text-indent:-24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Organization</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:9pt;">Surgery Partners, Inc.</font><font style="font-family:inherit;font-size:9pt;">,</font><font style="font-family:inherit;font-size:10pt;"> a </font><font style="font-family:inherit;font-size:9pt;">Delaware corporation (together with its subsidiaries, the “Company”), was formed April 2, 2015, as a holding company for the purpose of facilitating an initial public offering (the “IPO”) of shares of common stock. Prior to September 30, 2015, the Company conducted business through Surgery Center Holdings, Inc. and its subsidiaries. Surgery Center Holdings, LLC was and is the sole indirect owner of the equity interests of Surgery Center Holdings, Inc. and has no other material assets. On October 1, 2015, the Company completed its IPO of </font><font style="font-family:inherit;font-size:9pt;">14,285,000</font><font style="font-family:inherit;font-size:9pt;"> shares of common stock at an offering price of $</font><font style="font-family:inherit;font-size:9pt;">19.00</font><font style="font-family:inherit;font-size:9pt;"> per share.</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">On September 30, 2015, Surgery Partners, Inc. became the direct parent and sole member of Surgery Center Holdings, LLC (the "Reorganization"). In the Reorganization, all of the equity interests held by the pre-IPO owners of Surgery Center Holdings, LLC were contributed to Surgery Partners, Inc. in exchange for </font><font style="font-family:inherit;font-size:9pt;">33,871,990</font><font style="font-family:inherit;font-size:9pt;"> shares of common stock of Surgery Partners, Inc. and certain rights to additional payments under a tax receivable agreement. After giving effect to the Reorganization, Surgery Partners, Inc. is a holding company, and its sole material asset is an equity interest in Surgery Center Holdings, LLC. The Company's condensed consolidated financial statements for periods prior to the Reorganization represent the historical operating results and financial position of Surgery Center Holdings, Inc. and certain of its subsidiaries.</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:9pt;">As of </font><font style="font-family:inherit;font-size:9pt;">September 30, 2016</font><font style="font-family:inherit;font-size:9pt;">, the Company owned and operated a national network of surgical facilities and ancillary services in </font><font style="font-family:inherit;font-size:9pt;">29</font><font style="font-family:inherit;font-size:9pt;"> states.  The surgical facilities, which include ASCs and surgical hospitals, primarily provide non-emergency surgical procedures across many specialties, including, among others, otolaryngology</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:9pt;">("ENT"), gastroenterology</font><font style="font-family:inherit;font-size:10pt;"> ("</font><font style="font-family:inherit;font-size:9pt;">GI"), general surgery, ophthalmology, orthopedics, cardiology and pain management. The Company's surgical hospitals provide services such as diagnostic imaging, laboratory, obstetrics, oncology, pharmacy, physical therapy and wound care. Ancillary services are comprised of a diagnostic laboratory, multi-specialty physician practices, urgent care facilities, anesthesia services, optical services and specialty pharmacy services. </font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> As of </font><font style="font-family:inherit;font-size:9pt;">September 30, 2016</font><font style="font-family:inherit;font-size:9pt;">, the Company owned or operated a portfolio of </font><font style="font-family:inherit;font-size:9pt;">104</font><font style="font-family:inherit;font-size:9pt;"> surgical facilities, comprised of </font><font style="font-family:inherit;font-size:9pt;">99</font><font style="font-family:inherit;font-size:9pt;"> ASCs and </font><font style="font-family:inherit;font-size:9pt;">five</font><font style="font-family:inherit;font-size:9pt;"> surgical hospitals. The Company owns these facilities in partnership with physicians and, in some cases, healthcare systems in the markets and communities it serves. The Company owned a majority interest in </font><font style="font-family:inherit;font-size:9pt;">73</font><font style="font-family:inherit;font-size:9pt;"> of the surgical facilities and consolidated </font><font style="font-family:inherit;font-size:9pt;">93</font><font style="font-family:inherit;font-size:9pt;"> of these facilities for financial reporting purposes. In addition, the Company owned or operated a network of </font><font style="font-family:inherit;font-size:9pt;">53</font><font style="font-family:inherit;font-size:9pt;"> physician practices.</font></div></div>
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Reclassifications</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Certain reclassifications have been made to the comparative periods' financial statements to conform to the three</font><font style="font-family:inherit;font-size:9pt;"> and nine </font><font style="font-family:inherit;font-size:9pt;">months ended </font><font style="font-family:inherit;font-size:9pt;">September 30, 2016</font><font style="font-family:inherit;font-size:9pt;"> presentation. </font></div></div>
	us-gaap	Revenue Recognition Sales Of Services RevenueRecognitionSalesOfServices	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">Other service revenues.</font><font style="font-family:inherit;font-size:9pt;font-style:italic;font-weight:bold;"> </font><font style="font-family:inherit;font-size:9pt;"> Optical service revenues consist of product sales from the Company's optical laboratories as well as handling charges billed to the members of the Company's optical products purchasing organization and sales from the Company's marketing products and services business. The Company's optical products purchasing organization negotiates volume buying discounts with optical products manufacturers. The buying discounts and any handling charges billed to the members of the buying group represent the revenue recognized for financial reporting purposes. Revenue is recognized as orders are shipped to members. The Company bases its estimates for sales returns and discounts on historical experience and has not experienced significant fluctuations between estimated and actual return activity and discounts given. The Company's optical laboratories manufacture and distribute corrective lenses and eyeglasses to ophthalmologists and optometrists. Revenue is recognized when product is shipped, net of allowance for discounts. The Company's marketing products and services businesses recognize revenue when product is shipped or services are rendered. </font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other revenues include management and administrative service fees derived from the non-consolidated facilities that the Company accounts for under the equity method, management of surgical facilities in which it does not own an interest, and management services provided to physician practices for which the Company is not required to provide capital or additional assets. The fees derived from these management arrangements are based on a predetermined percentage of the revenues of each facility or practice and are recognized in the period in which services are rendered.</font></div></div><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Revenues</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company recognizes revenues in the period in which the services are performed. Patient service revenues and receivables from third-party payors are recorded net of estimated contractual adjustments and allowances, which the Company estimates based on the historical trend of its cash collections and contractual write-offs, accounts receivable agings, established fee schedules, contracts with payors and procedure statistics.</font></div></div><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">Patient service revenues.</font><font style="font-family:inherit;font-size:9pt;"> The fee charged for healthcare procedures performed in surgical facilities varies depending on the type of service provided, but usually includes all charges for usage of an operating room, a recovery room, special equipment, medical supplies, nursing staff and medications. The fee does not normally include professional fees charged by the patient’s surgeon, anesthesiologist or other attending physician, which are billed directly by such physicians to the patient or third-party payor.  However, in several surgical facilities, the Company charges for anesthesia services. Ancillary service revenues include fees for patient visits to the Company's physician practices, pharmacy services and diagnostic tests ordered by physicians. Patient service revenues are recognized on the date of service, net of estimated contractual adjustments and discounts from third-party payors, including Medicare and Medicaid.  Changes in estimated contractual adjustments and discounts are recorded in the period of change.</font></div></div>
	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and footnotes. Examples include, but are not limited to, estimates of accounts receivable allowances, professional and general liabilities and the estimate of deferred tax assets or liabilities. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. All adjustments are of a normal, recurring nature. Actual results could differ from those estimates.</font></div></div>

Files In Submission

Name	View Source	Status
0001638833-16-000055-index-headers.html	Edgar Link	pending
0001638833-16-000055-index.html	Edgar Link	pending
0001638833-16-000055.txt	Edgar Link	pending
0001638833-16-000055-xbrl.zip	Edgar Link	pending
exhibit101firstamendmentto.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
q3201610-qfiling.htm	Edgar Link	pending
q32016exhibit311.htm	Edgar Link	pending
q32016exhibit312.htm	Edgar Link	pending
q32016exhibit321.htm	Edgar Link	pending
q32016exhibit322.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
sgry-20160930.xml	Edgar Link	completed
sgry-20160930.xsd	Edgar Link	pending
sgry-20160930_cal.xml	Edgar Link	unprocessable
sgry-20160930_def.xml	Edgar Link	unprocessable
sgry-20160930_lab.xml	Edgar Link	unprocessable
sgry-20160930_pre.xml	Edgar Link	unprocessable
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SGRY
Surgery Partners, Inc. Stock $sgry

2016 Q4 Form 10-Q Financial Statement

#000163883316000055 Filed on November 10, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SGRY Surgery Partners, Inc. Stock $sgry

2016 Q4 Form 10-Q Financial Statement

#000163883316000055 Filed on November 10, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SGRY
Surgery Partners, Inc. Stock $sgry